Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine for Geriatric Bipolar Depression
NCT00621842Phase 3Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Jan 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lamotrigine in bipolar disorder (BD), sponsored by University Hospitals Cleveland Medical Center. Primary endpoint: Montgomery Asberg Depression Rating Scale at 12 weeks. Started Jan 2008; status: completed.
02
Drugs
lamotrigine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00621842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00621842.